Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 12/20 | 0.60 |
| ▸ | HPGD | P15428 | 6/20 | 0.60 |
| ▸ | HSD17B10 | Q99714 | 5/20 | 0.60 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.60 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.56 |
| ▸ | POLB | P06746 | 1/20 | 0.56 |
| ▸ | MAPK1 | P28482 | 5/20 | 0.55 |
| ▸ | MEN1 | O00255 | 3/20 | 0.55 |
| ▸ | LMNA | P02545 | 1/20 | 0.55 |
| ▸ | ACHE | P22303 | 1/20 | 0.54 |
| ▸ | MAPT | P10636 | 2/20 | 0.53 |
| ▸ | NPC1 | O15118 | 2/20 | 0.50 |
| ▸ | USP2 | O75604 | 1/20 | 0.50 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.50 |
| ▸ | MAOA | P21397 | 1/20 | 0.49 |
| ▸ | RAB9A | P51151 | 1/20 | 0.49 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10912020 | 0.80 | ALDH1A1 (0.48) | ALDH1A1HPGDHSD17B10KDM4EKMT2A | |
| SCHEMBL14557208 | 0.79 | KLK7 (0.57) | ALDH1A1HPGDKDM4EKMT2APOLB | |
| SCHEMBL10912534 | 0.77 | HPGD (0.49) | ALDH1A1HPGDHSD17B10KDM4EKMT2A | |
| SCHEMBL13486970 | 0.77 | ALDH1A1 (0.46) | ALDH1A1HPGDHSD17B10KDM4EKMT2A | |
| SCHEMBL17946077 | 0.77 | ALDH1A1 (0.75) | ALDH1A1HSD17B10KDM4EKMT2APOLB | |
| SCHEMBL8619433 | 0.76 | KDM4E (0.53) | ALDH1A1HSD17B10KDM4EKMT2AMAPK1 | |
| SCHEMBL2884714 | 0.76 | KDM4E (0.49) | ALDH1A1HSD17B10KDM4EKMT2AMAPK1 | |
| SCHEMBL28415110 | 0.76 | ALDH1A1 (0.57) | ALDH1A1HPGDHSD17B10KDM4EKMT2A | |
| SCHEMBL8502643 | 0.76 | KDM4E (0.70) | ALDH1A1HSD17B10KDM4EKMT2APOLB | |
| SCHEMBL17946339 | 0.76 | KDM4E (0.70) | ALDH1A1HSD17B10KDM4EKMT2APOLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220017527-A1 | NOVEL PROCEDURE FOR THE FORMATION OF 2H-BENZOTRIAZOLE BODIES AND CONGENERS | BASF SE (DE) | 2022-01-20 | — | — | US | disclosed |
| WO-2020114936-A1 | NOVEL PROCEDURE FOR THE FORMATION OF 2H-BENZOTRIAZOLE BODIES AND CONGENERS | BASF SE (DE) | 2020-06-11 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220017527-A1 | NOVEL PROCEDURE FOR THE FORMATION OF 2H-BENZOTRIAZOLE BODIES AND CONGENERS | GABBR1, GABBR2, SULT2A1 | ALDH1A1 488/4885HPGD 2675/4885HSD17B10 430/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.